Infinitum Asset Management

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 27, 2023	ArriVent Biopharma	$155.0M Series B	Elena Viboch, James Healy	AIHC Capital, Catalio Capital Management, HBM Healthcare Investments, Hongshan Capital Group (Sequoia Capital China), Lilly Asia Ventures, Octagon Capital, Carl Gordon, Shanghai Healthcare Capital, Sirona Capital, Terra Magnum Capital Partners, Unicorn Capital, Zoo Capital

Total Raised

N/A

Valuation

N/A